Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adaptive radiotherapy: The Elekta Unity MR-linac concept.
Winkel D, Bol GH, Kroon PS, van Asselen B, Hackett SS, Werensteijn-Honingh AM, Intven MPW, Eppinga WSC, Tijssen RHN, Kerkmeijer LGW, de Boer HCJ, Mook S, Meijer GJ, Hes J, Willemsen-Bosman M, de Groot-van Breugel EN, Jürgenliemk-Schulz IM, Raaymakers BW. Winkel D, et al. Among authors: de boer hcj. Clin Transl Radiat Oncol. 2019 Apr 2;18:54-59. doi: 10.1016/j.ctro.2019.04.001. eCollection 2019 Sep. Clin Transl Radiat Oncol. 2019. PMID: 31341976 Free PMC article.
Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator.
den Hartogh MD, de Boer HCJ, de Groot-van Breugel EN, van der Voort van Zyp JRN, Hes J, van der Heide UA, Pos F, Haustermans K, Depuydt T, Jan Smeenk R, Kunze-Busch M, Raaymakers BW, Kerkmeijer LGW. den Hartogh MD, et al. Among authors: de boer hcj, de groot van breugel en. Phys Imaging Radiat Oncol. 2019 Jul 15;11:16-20. doi: 10.1016/j.phro.2019.07.002. eCollection 2019 Jul. Phys Imaging Radiat Oncol. 2019. PMID: 33458271 Free PMC article.
Delivered dose quantification in prostate radiotherapy using online 3D cine imaging and treatment log files on a combined 1.5T magnetic resonance imaging and linear accelerator system.
Kontaxis C, de Muinck Keizer DM, Kerkmeijer LGW, Willigenburg T, den Hartogh MD, van der Voort van Zyp JRN, de Groot-van Breugel EN, Hes J, Raaymakers BW, Lagendijk JJW, de Boer HCJ. Kontaxis C, et al. Among authors: de boer hcj. Phys Imaging Radiat Oncol. 2020 Jul 13;15:23-29. doi: 10.1016/j.phro.2020.06.005. eCollection 2020 Jul. Phys Imaging Radiat Oncol. 2020. PMID: 33458322 Free PMC article.
Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator.
Willigenburg T, de Muinck Keizer DM, Peters M, Claes A, Lagendijk JJW, de Boer HCJ, van der Voort van Zyp JRN. Willigenburg T, et al. Among authors: de boer hcj. Clin Transl Radiat Oncol. 2021 Jan 14;27:50-56. doi: 10.1016/j.ctro.2021.01.002. eCollection 2021 Mar. Clin Transl Radiat Oncol. 2021. PMID: 33532630 Free PMC article.
Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trial.
Groen VH, Zuithoff NPA, van Schie M, Monninkhof EM, Kunze-Busch M, de Boer HCJ, van der Voort van Zyp J, Pos FJ, Smeenk RJ, Haustermans K, Isebaert S, Draulans C, Depuydt T, Verkooijen HM, van der Heide UA, Kerkmeijer LGW. Groen VH, et al. Among authors: de boer hcj. Radiother Oncol. 2021 Sep;162:98-104. doi: 10.1016/j.radonc.2021.06.033. Epub 2021 Jun 29. Radiother Oncol. 2021. PMID: 34214614 Free article. Clinical Trial.
From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial.
De Cock L, Draulans C, Pos FJ, Isebaert S, De Roover R, van der Heide UA, Smeenk RJ, Kunze-Busch M, van der Voort van Zyp J, de Boer H, Kerkmeijer LGW, Haustermans K. De Cock L, et al. Radiother Oncol. 2023 Aug;185:109713. doi: 10.1016/j.radonc.2023.109713. Epub 2023 May 11. Radiother Oncol. 2023. PMID: 37178932 Clinical Trial.
49 results